A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin's lymphoma.
Laurens
L
Nieuwenhuizen
Fred J
FJ
Verzijlbergen
Ed
E
Wiltink
Jan C
JC
Grutters
Douwe H
DH
Biesma
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D019788:Fluorodeoxyglucose F18; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy*; D011014:Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000069283:Rituximab